UBS analyst Alex Ye upgrades FinVolution Gr (NYSE:FINV) from Neutral to Buy.
HC Wainwright & Co. Maintains Buy on HIVE Blockchain Techs, Lowers Price Target to $5
HC Wainwright & Co. analyst Kevin Dede maintains HIVE Blockchain Techs (NASDAQ:HIVE) with a Buy and lowers the price target from $7 to $5.